Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00168259

Enrollment

Registered

2005-09-15

Start date

2004-12-31

Completion date

2009-12-31

Last updated

2012-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CMV Infection, HIV Infection

Keywords

Treatment Naive, HIV

Brief summary

The study is designed to evaluate interferon responses to CMV in HIV positive individuals and a component will look at interferon responses to CMV in HIV positive individuals over time after commencement of antiretroviral therapy. We will also look at the correlation between CD4 T cell numbers and HLA type with the interferon response.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. HIV positive with history of documented HCV infection 2. Over 18 years old 3. HIV positive 4. Antiretroviral naive, starting on antiretroviral therapy

Countries

Australia

Outcome results